Dana-Farber Wins Approval for $50M Cancer Treatment Center

A new cancer treatment center just got the green light in Boston, bringing hope to patients across Massachusetts who need advanced care.

The Massachusetts Public Health Council approved Dana-Farber Cancer Institute's plan to build a $50 million proton therapy center on Wednesday. The decision came after the institute addressed concerns about making the treatment accessible to low-income patients and those living outside Boston.

Proton therapy represents a major advancement in cancer treatment. Unlike traditional radiation, it targets tumors with precision while minimizing damage to surrounding healthy tissue, making it especially valuable for treating cancers near vital organs or in children.

The new 4,500-square-foot facility will be located at 35 Binney Street in Boston's Longwood Medical Area. Once complete, it will be the fourth proton therapy center in Massachusetts, expanding access to this life-saving technology.

Last month, the council initially delayed approval, asking Dana-Farber to do more for patients on MassHealth (the state's Medicaid program) and those in rural areas. The institute responded with commitments to improve equitable access, convincing council members that cancer care shouldn't depend on where you live or your insurance coverage.

The Ripple Effect

This decision means more than just one new building. Proton therapy often allows patients to maintain their quality of life during treatment, with fewer side effects than traditional radiation.

For families facing cancer diagnoses, having multiple proton therapy centers across the state reduces travel burdens during an already challenging time. Parents won't need to uproot their lives or choose between treatment quality and staying close to home.

The focus on equitable access also sets an important precedent. By requiring Dana-Farber to address coverage for MassHealth patients upfront, the council ensured that cutting-edge treatment won't just serve those who can afford it.

Advanced cancer care is coming to more patients who need it most.